Canine IL-6 Recombinant: Implications for Immunotherapy and Veterinary Medicine
Abstract:
Interleukin-6 (IL-6) plays a pivotal role in the immune response and inflammation regulation in various species, including canines. The advent of recombinant DNA technology has enabled the production of Canine IL-6 Recombinant (cIL-6r), opening new avenues for research in immunotherapy and veterinary medicine. This paper delves into the significance of cIL-6r, its production methods, and its potential applications in the treatment of inflammatory and autoimmune diseases in dogs.
Introduction:
Interleukin-6 is a multifunctional cytokine that exerts its effects on a wide range of physiological processes, including immune responses, hematopoiesis, and inflammation. In the canine immune system, IL-6 plays a crucial role in coordinating immune cell activation, antibody production, and acute phase responses. Recombinant IL-6 production has emerged as a promising strategy to harness its therapeutic potential.
Methods:
The production of cIL-6r involves recombinant DNA technology, where the canine IL-6 gene is inserted into an expression vector and transfected into a suitable host cell line, typically bacterial or mammalian cells. The recombinant protein is then purified using various chromatographic techniques to ensure high purity and biological activity.
Applications:
Canine IL-6 Recombinant holds immense promise in various applications within veterinary medicine. Its immunomodulatory properties make it a potential candidate for treating conditions such as immune-mediated diseases, inflammatory disorders, and certain types of cancer in dogs. Additionally, cIL-6r can be utilized to stimulate immune responses in vaccines, thereby enhancing their efficacy.
Challenges and Future Directions:
While cIL-6r shows great potential, its therapeutic use requires comprehensive studies to establish optimal dosages, safety profiles, and potential side effects. Long-term effects and potential interactions with existing treatments must also be explored.
Conclusion:
The advent of Canine IL-6 Recombinant marks a significant advancement in veterinary medicine, offering new avenues for immunotherapy and disease management in dogs. With further research and development, cIL-6r could become an invaluable tool in treating various conditions, ultimately enhancing the health and well-being of our canine companions.
What is the molecular weight/Mw of IL6 CANINE Protein?
IL6 CANINE Protein has a total Mw of 22kDa.
What is the source or expression system of IL6 CANINE Protein?
Sf9, Baculovirus cells.
What is the Purity of IL6 CANINE Protein?
IL6 CANINE Protein is >95% pure as determined by SDS-PAGE.
What is the Biological Activity of IL6 CANINE Protein?
The biological functionality of IL6 CANINE Protein will be determined in the future.
What is the amino acid sequence of IL6 CANINE Protein?
FPTPGPLAGD SKDDATSNSL PLTSANKVEE LIKYILGKIS ALRKEMCDKF NKCEDSKEAL AENNLHLPKL EGKDGCFQSG FNQETCLTRI TTGLVEFQLH LNILQNNYEG DKENVKSVHM STKILVQMLK SKVKNQDEVT TPDPTTDASL QAILQSQDEC VKHTTIHLIL RSLEDFLQFS LRAVRIMLEH HHHHH.
What applications can IL6 CANINE Protein be used in?
IL6 CANINE Protein can probably be used in western blot, ELISA and Lateral Flow.
What is the endotoxin level for IL6 CANINE Protein?
The endotoxin level is minimal, IL6 CANINE Protein was purified using conventional chromatography techniques.
Who supplies recombinant IL6 CANINE that is in stock and available to order?
ProSpec has the protein in stock and available for immediate delivery.
Where can I order bulk mg quantities of IL6 CANINE?
ProSpec supplies bulk mg quantities at affordable prices that meets research and academic budgets.